Krx Aesthetics Biophase Molecular Night Peel Cream
NDC Package 84755-0005-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Krx Aesthetics Biophase Molecular Night Peel cream is indications and UsageKrX Aesthetics Biophase Molecular Night Peel (PHA/LHA) is indicated for topical use as an exfoliating treatment.Helps gently resurface the skin to improve texture, clarity, and brightness.Aids in the removal of dead skin cells while promoting a smoother, more radiant complexion.Recommended for use at night as part of a skincare regimen.Not intended for use on broken or inflamed skin. This formulation utilizes a cream delivery system. Marketed by Krx Resources Sdn. Bhd., this product is identified by NDC 84755-0005.

Identification & Billing

NDC Package Code
84755-0005-1
Package Description
2 U in 1 BOTTLE
Product Code
11-Digit Billing Format
84755000501

Clinical Specifications

Proprietary Name
Krx Aesthetics Biophase Molecular Night Peel
Non-Proprietary Name
Krx Aesthetics Biophase Molecular Night Peel
Substance Name
Gluconolactone; Salicyloyl Phytosphingosine
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Usage Information
Indications and UsageKrX Aesthetics Biophase Molecular Night Peel (PHA/LHA) is indicated for topical use as an exfoliating treatment.Helps gently resurface the skin to improve texture, clarity, and brightness.Aids in the removal of dead skin cells while promoting a smoother, more radiant complexion.Recommended for use at night as part of a skincare regimen.Not intended for use on broken or inflamed skin.

Regulatory & Marketing

Labeler Name
Krx Resources Sdn. Bhd.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
09-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84755-0005-1 identifies a specific commercial package of 2 u in 1 bottle of Krx Aesthetics Biophase Molecular Night Peel, a human over the counter drug labeled by Krx Resources Sdn. Bhd.. This cream is formulated for topical use and contains gluconolactone; salicyloyl phytosphingosine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Krx Resources Sdn. Bhd. on September 01, 2025. The current certification is valid through December 31, 2026.

How is this Krx Resources Sdn. Bhd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84755000501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
84755-0005-1
11-Digit CMS (5-4-2)
84755-0005-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.